Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon - Clinical Results from the Randomized, Single-Blinded, Controlled freeBILy-Gabon Trial.

Efficacy Praziquantel Pregnancy S. haematobium Safety Schistosomiasis

Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 15 06 2024
revised: 31 08 2024
accepted: 25 09 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: aheadofprint

Résumé

Despite evidence of praziquantel's safety for treating schistosomiasis in pregnancy, many countries withhold treatment. Only two randomized controlled trials have investigated praziquantel in pregnancy, none involving Schistosoma haematobium. Pregnant women during second trimester in Lambaréné (Gabon) were screened for S. haematobium infection using urine microscopy and circulating anodic antigen detection. Participants positive for either test were randomized (3:1) to single-dose praziquantel 40mg/kg during pregnancy versus no treatment during pregnancy. Investigators were blinded for allocation. Primary outcomes were reduction of egg- (ERR) and antigen production (IRR) while explorative outcomes included assessment of cure rate, adverse events, maternal hemoglobin levels maternal anemia prevalence at delivery, pregnancy outcomes, and newborn anthropometric parameters. Of 761 women screened 165 were eligible and randomized (intervention n=124, control n=41). 124 completed the study (n=90 and n=34, respectively). Tretament led to a significant higher ERR (95.0%[91%-97%] vs. 27.0%[-42%-63%]) and IRR (95%[91%-97%] vs. 56%[14%-78%]). Common adverse events were dizziness, nausea, and vomiting. Maternal anemia at delivery was significantly lower in the intervention group (OR:0.40[0.16;0.96],p=0.04). No increased risk for adverse pregnancy outcomes was observed. This first randomized controlled trial investigating praziquantel in pregnant women with S. haematobium found praziquantel to be safe, effective and reducing maternal anemia. We recommend treating confirmed infections to prevent morbidity in pregnant women.

Identifiants

pubmed: 39368731
pii: S1201-9712(24)00324-2
doi: 10.1016/j.ijid.2024.107253
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107253

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jacob Gerstenberg (J)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany. Electronic address: jacob.gerstenberg@posteo.de.

Yabo J Honkpehedji (YJ)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Leiden University for Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, the Netherlands; Fondation pour la Recherche Scientifique (FORS), Cotonou, Benin.

Jean-Claude Dejon-Agobe (JC)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Saidou Mahmoudou (S)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Mario Recker (M)

Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; University of Exeter College of Life and Environmental Sciences.

Romuald Beh Mba (RB)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Laboratoire de Biomathématiques et d'Estimations Forestières (LABEF), Université d'Abomey-Calavi (UAC).

Moustapha Nzamba Maloum (MN)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Romeo Laclong Lontchi (RL)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Paul A Nguema Moure (PAN)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; École Doctorale de Franceville (EDR), Franceville, Gabon.

Brice Meulah (B)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Leiden University for Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, the Netherlands.

Jeannot F Zinsou (JF)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; Fondation pour la Recherche Scientifique (FORS), Cotonou, Benin.

Jean-Ronald Edoa (JR)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Bayode R Adegbite (BR)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Michael Ramharter (M)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Sites Hamburg-Lübeck-Borstel-Riems; Germany.

Bertrand Lell (B)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Austria.

Selidji T Agnandji (ST)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Fondation pour la Recherche Scientifique (FORS), Cotonou, Benin.

Peter G Kremsner (PG)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; German Center for Infection Research (DZIF), Partner Site Tübingen, Germany.

Paul Lam Corstjens (PL)

Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.

Pytsje T Hoekstra (PT)

Leiden University for Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, the Netherlands.

Govert J van Dam (GJ)

Leiden University for Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, the Netherlands.

Andrea Kreidenweiss (A)

Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; German Center for Infection Research (DZIF), Partner Site Tübingen, Germany.

Ayola A Adegnika (AA)

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany; Leiden University for Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, the Netherlands; Fondation pour la Recherche Scientifique (FORS), Cotonou, Benin; German Center for Infection Research (DZIF), Partner Site Tübingen, Germany.

Classifications MeSH